# Drug-drug Interactions Between DZD9008 and Itraconazole/Carbamazepine

> **NCT05418582** · PHASE1 · COMPLETED · sponsor: **Dizal Pharmaceuticals** · enrollment: 40 (actual)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** DZD9008 and intraconazole
- **DRUG:** DZD9008 and carbamazepine

## Key facts

- **NCT ID:** NCT05418582
- **Lead sponsor:** Dizal Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-25
- **Primary completion:** 2022-06-01
- **Final completion:** 2022-12-08
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2023-06-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05418582

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05418582, "Drug-drug Interactions Between DZD9008 and Itraconazole/Carbamazepine". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05418582. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*